Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: A cross sectional study

British Medical Journal

Volumn 313, Issue 7053, 1996, Pages 344-346

  Walsh, L J ^a   Wong, C A ^a   Pringle, M ^b,c   Tattersfield, A E ^a,b  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b Department of Respiratory Medicine ^*

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DRUG USE; FEMALE; GENERAL PRACTITIONER; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; PROPHYLAXIS; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SCHOOL CHILD; UNITED KINGDOM;

EID: 0029787602     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.313.7053.344     Document Type: Article

References (24)

1. Kanis JA. The incidence of hip fracture in Europe. Osteoporosis Int 1993;1(suppl):S10-5.
2. Khosla S, Lufkin EG, Hodgson SF, Fitzpatrick LA, Melton LJ, III. Epidemiology and clinical features of osteoporosis in young individuals. Bone 1994;15:551-5.
3. Rice P, Simmons K, Carr R, Banatvala J. Near fatal chickenpox during prednisolone treatment. BMJ 1994;309:1069-70.
4. Wilson, S. Aiming for health in the year 2000: the annual report of the director of public health 1995. Nottingham: Nottingham Health District, 1995.
5. Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995;54:49-52.
6. Verstraeten A, Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis 1986;45:852-7.
7. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983;309:265-8.
8. Isaacs AJ, Britton AR, McPherson K. Utilisation of hormone replacement therapy by women doctors. BMJ 1995;311:1399-401.
9. Luengo M, Picado C, Del Rio L, Guaǹabens N, Montserrat JM, Setoain J. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study Thorax 1991;46:803-6.
10. Reid IR, King AR, Alexander CJ, Ibbertson HK. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet 1988;i:143-6.
11. Reid IR, Heap SW, King AR, Ibbertson HK. Two year follow-up of bisphosphonate (APD) treatment in steroid osteoporosis [letter]. Lancet 1988;ii:1144.
12. Adachi JD, Cranney A, Goldsmith CH, Bensen WG, Bianchi F, Cividino A, et al. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. J Rheumatol 1994;21:1922-6.
13. Mulder H, Struys A. Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss. Br J Rheumatol 1994;33.348-50.
14. Diamond T, McGuigan L, Barbagallo S, Bryant C. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women. Am J Med 1995;98:459-63.
15. Luengo M, Picado C, Del Rio L, Guanabens N, Montserrat JM, Setoain J. Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. A one-year follow-up study. Am Rev Respir Dis 1990;142:104-7.
16. Luengo M, Pons F, Martinez de Osaba MJ, Picado C. Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma; a two year follow up study. Thorax 1994;49:1099-102.
17. Lukert BP, Johnson BE, Robinson RG. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 1992;7:1063-9.
18. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, et al. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitrol and calcitonin. N Engl J Med 1993;328:1747-52.
19. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112:352-64.
20. Eastell R. Management of corticosteroid-induced osteoporosis. J Intern Med 1995;237:439-47.
21. Reid IR. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 1989;30:83-103.
22. Lukert BP. Glucocorticoid-induced bone loss: a neglected problem. Chest 1994;105:1640-1.
23. Spector TD, Sambrook PN. Steroid osteoporosis. BMJ 1993;307:519-20.
24. Sheldon TA, Raffle A, Watt I. Why the report of the Advisory Group on Osteoporosis undermines evidence based purchasing. BMJ 1996; 312:296-7.